EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 327 filers reported holding EXELIXIS INC in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,046,613 | +34.7% | 139,439 | +17.8% | 0.01% | +25.0% |
Q2 2023 | $2,261,151 | -8.5% | 118,337 | -6.9% | 0.00% | -20.0% |
Q1 2023 | $2,470,522 | +62.7% | 127,139 | +34.4% | 0.01% | +66.7% |
Q4 2022 | $1,518,155 | +0.9% | 94,567 | -1.5% | 0.00% | 0.0% |
Q3 2022 | $1,504,000 | -33.8% | 95,985 | -11.9% | 0.00% | -40.0% |
Q2 2022 | $2,271,000 | +20.5% | 108,983 | +13.6% | 0.01% | +25.0% |
Q1 2022 | $1,885,000 | +22.1% | 95,903 | +14.6% | 0.00% | +33.3% |
Q4 2021 | $1,544,000 | +16.7% | 83,721 | +34.4% | 0.00% | 0.0% |
Q3 2021 | $1,323,000 | +20.7% | 62,293 | +3.9% | 0.00% | +50.0% |
Q2 2021 | $1,096,000 | -16.8% | 59,955 | +3.3% | 0.00% | -33.3% |
Q1 2021 | $1,317,000 | +5.2% | 58,023 | -7.0% | 0.00% | 0.0% |
Q4 2020 | $1,252,000 | -16.4% | 62,390 | +1.3% | 0.00% | -25.0% |
Q3 2020 | $1,498,000 | -2.7% | 61,575 | -5.0% | 0.00% | -20.0% |
Q2 2020 | $1,540,000 | -11.5% | 64,841 | -35.7% | 0.01% | -28.6% |
Q1 2020 | $1,741,000 | – | 100,807 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |